125 related articles for article (PubMed ID: 3162904)
1. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
[TBL] [Abstract][Full Text] [Related]
3. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
[TBL] [Abstract][Full Text] [Related]
5. Penetration of enoxacin into human bronchial mucosa.
Marlin GE; Braude PD; Whelan AJ; Somogyi AA
Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
[TBL] [Abstract][Full Text] [Related]
6. Enoxacin distribution in human tissues after multiple oral administration.
Malmborg AS; Rannikko S
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
[TBL] [Abstract][Full Text] [Related]
7. Penetration of enoxacin into bronchial secretions.
Fong IW; Vandenbroucke A; Simbul M
Antimicrob Agents Chemother; 1987 May; 31(5):748-51. PubMed ID: 3475036
[TBL] [Abstract][Full Text] [Related]
8. [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
Morel C; Vergnaud M; Malbruny B; Benard Y
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):781-4. PubMed ID: 3309815
[TBL] [Abstract][Full Text] [Related]
9. The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.
Wolf R; Eberl R; Dunky A; Mertz N; Chang T; Goulet JR; Latts J
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():63-9. PubMed ID: 6389476
[TBL] [Abstract][Full Text] [Related]
10. The comparative pharmacokinetics of five quinolones.
Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
Bates SA; Elder MG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
[TBL] [Abstract][Full Text] [Related]
13. Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.
Heifetz CL; Bien PA; Cohen MA; Dombrowski ME; Griffin TJ; Malta TE; Sesnie JC; Shapiro MA; Wold SA
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():29-42. PubMed ID: 3129392
[TBL] [Abstract][Full Text] [Related]
14. The effect of age on the pharmacokinetics of enoxacin.
Dobbs BR; Gazeley LR; Campbell AJ; Edwards IR
Eur J Clin Pharmacol; 1987; 33(1):101-4. PubMed ID: 3480221
[TBL] [Abstract][Full Text] [Related]
15. Enoxacin in lower respiratory tract infections.
Wijnands WJ; van Griethuysen AJ; Vree TB; Van Klingeren B; van Herwaarden CL
J Antimicrob Chemother; 1986 Dec; 18(6):719-27. PubMed ID: 3469179
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
Wise R; Lockley R; Webberly M; Adhami ZN
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
[TBL] [Abstract][Full Text] [Related]
17. Intravenous enoxacin for the treatment of acute pyelonephritis: pharmacokinetic and clinical study.
Bailey RR; Walker RJ; Lynn KL; Donaldson IM; Peddie BA; Dobbs BR
Br J Clin Pharmacol; 1988 Feb; 25(2):223-8. PubMed ID: 3162809
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
Hamel B; Mottet N; Audran M; Costa P; Bressolle F
J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tissue penetration of enoxacin.
Wise R; Lockley R; Dent J; Webberly M
Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of enoxacin in elderly patients.
Wise R; Baker SL; Misra M; Griggs D
J Antimicrob Chemother; 1987 Mar; 19(3):343-50. PubMed ID: 3471751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
